Should Fitness Trackers Be Used to Assess Performance Status in Patients With Cancer?

Tony Berberabe, MPH @OncBiz_Wiz
Published: Sunday, Sep 23, 2018
Gillian Gresham, PhD

Gillian Gresham, PhD

Using wearable activity monitors may eventually supplement standard assessments of performance status (PS) and functionality that could inform clinicians, especially because objective evaluation of PS is difficult to determine. Patients spend most of their time outside of the clinic, self-report to providers, and undergo changes throughout treatment. Findings from a recent study at Cedars-Sinai Medical Center (CSMC) in Los Angeles, California, demonstrated the feasibility of using these wrist-worn devices to correlate with Eastern Cooperative Oncology Group (ECOG) PS and Karnofsky PS (KPS) scales.1 PS is affected by bias, resulting in patient activity being over- or underreported, which can affect short- and long-term treatment plans and clinical trial eligibility.

 

Heat Map of Average Activity Intensity for Each Patient Over a 24-hour Period, as Measured by a Wearable Activity Monitor and Sorted by ECOG PS Categories

Heat Map of Average Activity Intensity for Each Patient Over a 24-hour Period, as Measured by a Wearable Activity Monitor and Sorted by ECOG PS Categories

 


... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Archived Version of a Live Webcast: Virtual Current Trends™: European Perspectives on the Advancing Role of CAR T-Cell Therapy in Hematologic MalignanciesJun 29, 20192.0
Community Practice Connections™: Practical Application of Sequencing for EGFR-Mutant Lung Cancers: A Focus on Recent Evidence and Key Next Steps in TrialsJun 29, 20192.5
Publication Bottom Border
Border Publication
x